Zobrazeno 1 - 10 of 436 pro vyhledávání: '"L. Flamm"'
1
Akademický článek
Thrombocytopenia and Procedural Prophylaxis in the Era of Thrombopoietin Receptor Agonists
Autor: Kathy M. Nilles, Stephen H. Caldwell, Steven L. Flamm
Publikováno v: Hepatology Communications, Vol 3, Iss 11, Pp 1423-1434 (2019)
Thrombocytopenia is common in patients with advanced liver disease. These patients frequently require invasive diagnostic or therapeutic procedures in the setting of thrombocytopenia. A common platelet goal before such procedures is ≥50,000/μL, bu
Externí odkaz: https://doaj.org/article/a08c8491f22c4900825151edd172dd36
Zobrazit plný text záznamu
2
Alcohol-Related Liver Disease Including New Developments
Autor: Parita Virendra, Patel, Steven L, Flamm
Publikováno v: Clinics in Liver Disease. 27:157-172
The prevalence of alcohol consumption, alcohol use disorder (AUD), and alcohol-related liver disease (ALD) has exponentially increased over the last several years and rates continue to increase. Significant alcohol use can cause progression from stea
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b4fd4406d02ae5184f4dcbbaf73a0ce
https://doi.org/10.1016/j.cld.2022.08.005
Zobrazit plný text záznamu
4
Pharmacokinetic Assessment and Treatment Effect of Lusutrombopag in Child–Pugh Class C Patients: Review of Patient Data from Two Clinical Studies and Post-Marketing Surveillance
Autor: Steven L, Flamm, Markus, Peck-Radosavljevic, Takahiro, Fukuhara, Roy, Bentley, Takayuki, Katsube, Toshimitsu, Ochiai, Takeshi, Kano, Eri, Tsukimura, Ritsue, Sasaki, Yukio, Osaki
Publikováno v: Advances in Therapy. 39:4285-4298
Patients with thrombocytopenia and chronic liver disease are at increased risk of bleeding during invasive procedures due to low platelet counts. Lusutrombopag, an orally active thrombopoietin receptor agonist, increases platelet count and reduces th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::206f7866cf246432e29f5fded54da2a4
https://doi.org/10.1007/s12325-022-02237-8
Zobrazit plný text záznamu
8
Akademický článek
Rifaximin has the potential to prevent complications of cirrhosis
Autor: Steven L. Flamm, Kevin D. Mullen, Zeev Heimanson, Arun J. Sanyal
Publikováno v: Therapeutic Advances in Gastroenterology, Vol 11 (2018)
Background: Cirrhosis-related complications are associated with poor prognosis. With our analyses, we examined the potential benefit of rifaximin in reducing the risk of developing cirrhosis-related complications. Methods: Adults with cirrhosis and h
Externí odkaz: https://doaj.org/article/e422f1463ea14615bd40bf03572ae4d2
Zobrazit plný text záznamu
9
Overt Hepatic Encephalopathy: Current Pharmacologic Treatments and Improving Clinical Outcomes
Autor: Robert S. Brown, Robert S. Rahimi, Steven L. Flamm, Kimberly A. Brown
Publikováno v: The American Journal of Medicine. 134:1330-1338
Overt hepatic encephalopathy is a generally reversible neurologic complication of cirrhosis. Overt hepatic encephalopathy has been associated with poor hospitalization- and mortality-related outcomes, which is important given increasing hepatic encep
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b774d6be310cf947ea5a967cbffe2d3
https://doi.org/10.1016/j.amjmed.2021.06.007
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje